ESC 365 - Novel insights of LAA treatment for atrial fibrillation and stroke prevention

EHRA Premium Access

Novel insights of LAA treatment for atrial fibrillation and stroke prevention

Event: EHRA 2018

Topic: Stroke – Clinical

Session type: New ESC Guidelines

Date: 19 March 2018

Time: 16:30 - 18:00

Congress Session

6 presentations in this session

This session is supported by Abbott and Boston Scientific in the form of an educational grant. The scientific programme has not been influenced in any way by these sponsors.

Stroke prevention or bleeding: how to weigh the results of clinical trials

Speaker: Professor L. Boersma (Nieuwegein, NL)

The role of the LAA for AF and stroke: fact or fiction

Speaker: Professor T. Lewalter (Munich, DE)

LAA closure concomitant to AF ablation - The surgical perspective

Speaker: Associate Professor S. Salzberg (Zurich, CH)

LAA closure concomitant to AF ablation - The EP perspective

Speaker: Professor C. Tondo (Milan, IT)

New strategies for anticoagulation therapy after LAA closure

Speaker: Professor M. Glikson (Jerusalem, IL)

5 speakers from this session

Professor Lucas Boersma

St Antonius Hospital, Department of Cardiology, Nieuwegein (Netherlands (The))

21 presentations

0 follower

Professor Thorsten Lewalter

Hospital Munich South, Munich (Germany)

8 presentations

0 follower

Associate Professor Sacha Salzberg

, Zurich (Switzerland)

1 presentation

0 follower

Professor Claudio Tondo

Heart Rhythm Center Monzino Cardiac Center, Milan (Italy)

12 presentations

0 follower

Professor Michael Glikson

Shaare Zedek Medical Center, Jerusalem (Israel)

14 presentations

0 follower

This platform is supported by